Nath Bio Genes India Share Price
Sector: Crops
You have to be logged in to add this to Watchlist.
Login or Register
172.30 +0.25 (0.15%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
172.3
Today’s High
180
52 Week Low
167.5
52 Week High
264.5
173.62 +1.27 (0.74%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
171.48
Today’s High
179.9
52 Week Low
167.15
52 Week High
264.31
Key Metrics
- Market Cap (In Cr) 327.53
- Beta 1.89
- Div. Yield (%) 1.16
- P/B 0.54
- TTM P/E 10.42
- Peg Ratio -0.78
- Sector P/E 22.03
- D/E 0.2
- Open Price 180
- Prev Close 172.05
Nath Bio Genes India Analysis
Price Analysis
-
1 Week-3.49%
-
3 Months-24.95%
-
6 Month-9.62%
-
YTD-16.9%
-
1 Year-16.6%
Risk Meter
- 41% Low risk
- 41% Moderate risk
- 41% Balanced Risk
- 41% High risk
- 41% Extreme risk
Nath Bio Genes India News
Nath Bio Genes India Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 332.62
- Selling/ General/ Admin Expenses Total
- 121.25
- Depreciation/ Amortization
- 3.26
- Other Operating Expenses Total
- 27.31
- Total Operating Expense
- 285.4
- Operating Income
- 47.23
- Net Income Before Taxes
- 38.12
- Net Income
- 39.62
- Diluted Normalized EPS
- 19.31
- Period
- 2024
- Total Assets
- 880.23
- Total Liabilities
- 270.31
- Total Equity
- 609.92
- Tangible Book Valueper Share Common Eq
- 316.31
- Period
- 2024
- Cashfrom Operating Activities
- 80.5
- Cashfrom Investing Activities
- -27.4
- Cashfrom Financing Activities
- -13.68
- Net Changein Cash
- 39.41
- Period
- 2023
- Total Revenue
- 301.36
- Selling/ General/ Admin Expenses Total
- 35.3
- Depreciation/ Amortization
- 3.01
- Other Operating Expenses Total
- 102.43
- Total Operating Expense
- 255.63
- Operating Income
- 45.73
- Net Income Before Taxes
- 36.16
- Net Income
- 35.01
- Diluted Normalized EPS
- 18.42
- Period
- 2023
- Total Assets
- 792.8
- Total Liabilities
- 219.62
- Total Equity
- 573.17
- Tangible Book Valueper Share Common Eq
- 296.12
- Period
- 2023
- Cashfrom Operating Activities
- 38.37
- Cashfrom Investing Activities
- -2.88
- Cashfrom Financing Activities
- -1.67
- Net Changein Cash
- 33.81
- Period
- 2022
- Total Revenue
- 278.36
- Selling/ General/ Admin Expenses Total
- 60.54
- Depreciation/ Amortization
- 3.08
- Other Operating Expenses Total
- 56.52
- Total Operating Expense
- 332.99
- Operating Income
- -54.63
- Net Income Before Taxes
- -63.39
- Net Income
- -67.34
- Diluted Normalized EPS
- -5.07
- Period
- 2022
- Total Assets
- 741.91
- Total Liabilities
- 199.94
- Total Equity
- 541.97
- Tangible Book Valueper Share Common Eq
- 278.86
- Period
- 2022
- Cashfrom Operating Activities
- 17.04
- Cashfrom Investing Activities
- -19.87
- Cashfrom Financing Activities
- -22.23
- Net Changein Cash
- -25.05
- Period
- 2021
- Total Revenue
- 307.56
- Selling/ General/ Admin Expenses Total
- 58.1
- Depreciation/ Amortization
- 2.82
- Other Operating Expenses Total
- 47.44
- Total Operating Expense
- 243.54
- Operating Income
- 64.02
- Net Income Before Taxes
- 56.75
- Net Income
- 55.66
- Diluted Normalized EPS
- 29.28
- Period
- 2021
- Total Assets
- 789.51
- Total Liabilities
- 176.23
- Total Equity
- 613.28
- Tangible Book Valueper Share Common Eq
- 315.54
- Period
- 2021
- Cashfrom Operating Activities
- 1.11
- Cashfrom Investing Activities
- -10.28
- Cashfrom Financing Activities
- 16.4
- Net Changein Cash
- 7.23
- Period
- 2020
- Total Revenue
- 279.89
- Selling/ General/ Admin Expenses Total
- 49.98
- Depreciation/ Amortization
- 1.45
- Other Operating Expenses Total
- 47.79
- Total Operating Expense
- 226.66
- Operating Income
- 53.23
- Net Income Before Taxes
- 48.51
- Net Income
- 50.48
- Diluted Normalized EPS
- 26.52
- Period
- 2020
- Total Assets
- 729.95
- Total Liabilities
- 172.33
- Total Equity
- 557.62
- Tangible Book Valueper Share Common Eq
- 285.44
- Period
- 2020
- Cashfrom Operating Activities
- 9.47
- Cashfrom Investing Activities
- -14.44
- Cashfrom Financing Activities
- 5.56
- Net Changein Cash
- 0.6
- Period
- 2019
- Total Revenue
- 230.93
- Selling/ General/ Admin Expenses Total
- 41.71
- Depreciation/ Amortization
- 1.45
- Other Operating Expenses Total
- 38.1
- Total Operating Expense
- 189.13
- Operating Income
- 41.8
- Net Income Before Taxes
- 38.87
- Net Income
- 38.43
- Diluted Normalized EPS
- 20.22
- Period
- 2019
- Total Assets
- 646.06
- Total Liabilities
- 138.48
- Total Equity
- 507.58
- Tangible Book Valueper Share Common Eq
- 265.2
- Period
- 2019
- Cashfrom Operating Activities
- -22.94
- Cashfrom Investing Activities
- -20.48
- Cashfrom Financing Activities
- 20.14
- Net Changein Cash
- -23.28
- Period
- 2024-09-30
- Total Revenue
- 32.19
- Selling/ General/ Admin Expenses Total
- 12.08
- Depreciation/ Amortization
- 0.82
- Other Operating Expenses Total
- 2.83
- Total Operating Expense
- 28.2
- Operating Income
- 3.99
- Net Income Before Taxes
- 1.09
- Net Income
- 1.11
- Diluted Normalized EPS
- 0.53
- Period
- 2024-09-30
- Total Assets
- 828.48
- Total Liabilities
- 188.21
- Total Equity
- 640.27
- Tangible Book Valueper Share Common Eq
- 332.7
- Period
- 2024-09-30
- Cashfrom Operating Activities
- -83.71
- Cashfrom Investing Activities
- 0.32
- Cashfrom Financing Activities
- 8.05
- Net Changein Cash
- -75.33
- Period
- 2024-06-30
- Total Revenue
- 243.88
- Selling/ General/ Admin Expenses Total
- 76.76
- Depreciation/ Amortization
- 0.82
- Other Operating Expenses Total
- 67.41
- Total Operating Expense
- 208.16
- Operating Income
- 35.71
- Net Income Before Taxes
- 33.6
- Net Income
- 33.35
- Diluted Normalized EPS
- 17.49
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 43.04
- Selling/ General/ Admin Expenses Total
- 33.75
- Depreciation/ Amortization
- 0.98
- Other Operating Expenses Total
- 14.01
- Total Operating Expense
- 39.68
- Operating Income
- 3.36
- Net Income Before Taxes
- 2.28
- Net Income
- 2.62
- Diluted Normalized EPS
- 0.81
- Period
- 2024-03-31
- Total Assets
- 880.23
- Total Liabilities
- 270.31
- Total Equity
- 609.92
- Tangible Book Valueper Share Common Eq
- 316.31
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 80.5
- Cashfrom Investing Activities
- -27.4
- Cashfrom Financing Activities
- -13.68
- Net Changein Cash
- 39.41
- Period
- 2023-12-31
- Total Revenue
- 31.74
- Selling/ General/ Admin Expenses Total
- 7.97
- Depreciation/ Amortization
- 0.76
- Other Operating Expenses Total
- 3.98
- Total Operating Expense
- 26.85
- Operating Income
- 4.89
- Net Income Before Taxes
- 2.09
- Net Income
- 3.82
- Diluted Normalized EPS
- 0.69
- Period
- 2023-12-31
- Period
- 2023-12-31
- Period
- 2023-09-30
- Total Revenue
- 22.57
- Selling/ General/ Admin Expenses Total
- 9.44
- Depreciation/ Amortization
- 0.76
- Other Operating Expenses Total
- 3.81
- Total Operating Expense
- 18.24
- Operating Income
- 4.32
- Net Income Before Taxes
- 1.95
- Net Income
- 1.6
- Diluted Normalized EPS
- 0.84
- Period
- 2023-09-30
- Total Assets
- 846.75
- Total Liabilities
- 242.71
- Total Equity
- 604.05
- Tangible Book Valueper Share Common Eq
- 312.8
- Period
- 2023-09-30
- Cashfrom Operating Activities
- -20.36
- Cashfrom Investing Activities
- -0.48
- Cashfrom Financing Activities
- -1.5
- Net Changein Cash
- -22.34
- Period
- 2023-06-30
- Total Revenue
- 235.28
- Selling/ General/ Admin Expenses Total
- 70.09
- Depreciation/ Amortization
- 0.76
- Other Operating Expenses Total
- 5.31
- Total Operating Expense
- 198.91
- Operating Income
- 36.37
- Net Income Before Taxes
- 33.72
- Net Income
- 33.5
- Diluted Normalized EPS
- 17.53
- Period
- 2023-06-30
- Period
- 2023-06-30
- Period
- 2023-03-31
- Total Revenue
- 44.99
- Selling/ General/ Admin Expenses Total
- 6.12
- Depreciation/ Amortization
- 0.99
- Other Operating Expenses Total
- 65.08
- Total Operating Expense
- 42.04
- Operating Income
- 2.94
- Net Income Before Taxes
- 1.67
- Net Income
- 1.44
- Diluted Normalized EPS
- 0.76
- Period
- 2023-03-31
- Total Assets
- 792.8
- Total Liabilities
- 219.62
- Total Equity
- 573.17
- Tangible Book Valueper Share Common Eq
- 296.12
- Period
- 2023-03-31
- Cashfrom Operating Activities
- 38.37
- Cashfrom Investing Activities
- -2.88
- Cashfrom Financing Activities
- -1.67
- Net Changein Cash
- 33.81
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Nath Bio Genes India Technical
Moving Average
SMA
- 5 Day176.62
- 10 Day182.75
- 20 Day186.64
- 50 Day202.67
- 100 Day218.25
- 300 Day208.07
Nath Bio Genes India Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Tierra Agrotech
- 60.59
- -0.15
- -0.25
- 105.17
- 50.44
- 338.89
- Uma Exports
- 97.75
- -1.75
- -1.76
- 151
- 47
- 330.49
- Nath Bio Genes India
- 172.3
- 0.25
- 0.15
- 264.5
- 167.5
- 327.44
- Halder Venture
- 897.15
- -0.85
- -0.09
- 948
- 214.3
- 283.56
- Dhunseri Tea & Industries
- 256
- 0.3
- 0.12
- 311.85
- 175
- 268.99
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Tierra Agrotech
- -
- 3.43
- -31.83
- -16.22
- Uma Exports
- 32.55
- 1.78
- 15.99
- 1.42
- Nath Bio Genes India
- 9.2
- 0.55
- 3.99
- 7.56
- Halder Venture
- 24.41
- 4.8
- 25.3
- 2.25
- Dhunseri Tea & Industries
- -
- 0.53
- -4.12
- -8.81
Nath Bio Genes India Shareholding
Shareholding Pattern
*Promoter pledging: 7.47%
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 23-Oct-24
- Quarterly Results
- 07-Aug-24
- Quarterly Results
- 08-May-24
- Audited Results & Final Dividend
- 18-Jan-24
- Quarterly Results
- 16-Oct-23
- Quarterly Results
- 10-Aug-23
- Quarterly Results
- 22-Apr-23
- Audited Results & Final Dividend
- 14-Feb-23
- Quarterly Results
- 20-Oct-22
- Quarterly Results
- 13-Aug-22
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 17-Aug-24
- 08-May-24
- AGM
- 12-Mar-24
- 19-Jan-24
- EGM
- 11-Jul-23
- 23-May-23
- AGM
- 30-Jun-23
- 24-Apr-23
- AGM
- 27-Aug-21
- 24-Jun-21
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 08-May-24
- 09-Aug-24
- 09-Aug-24
- 2
- 24-Apr-23
- -
- 04-Jul-23
- 2
- 30-May-22
- -
- 23-Jun-22
- 2
- 24-Jun-21
- -
- 18-Aug-21
- 2